Real-World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi-Center Cohort Study.

Clin Transl Sci · 2026 · PMC13098360 · PMID 42012333

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although SALT scores decreased and improvement rates increased in this group, the changes did not reach statistical significance, suggesting that tofacitinib may offer limited benefits in non‐severe AA and highlighting the need for severity‐targeted treatment strategies.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.